Physician profile
Mary Brunner
NPI 1184779084
$1,866.88
in general payments reported to CMS, 2019-2025
17 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.57 · 2020: $171 · 2021: $103 · 2022: $724 · 2023: $161 · 2024: $258 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $507.83 | 2020-2025 | Rocklatan, Rhopressa, Simbrinza |
| Glaukos Corporation | $279.76 | 2022-2025 | Radius |
| Johnson & Johnson Vision Care, INC. | $206.30 | 2020-2024 | |
| Abbvie INC. | $162.45 | 2022-2025 | |
| Dompe US, INC. | $155.27 | 2021-2025 | Oxervate |
| Coopervision INC. | $123.04 | 2022 | |
| Sun Pharmaceutical Industries INC. | $107.67 | 2022 | |
| Sight Sciences, INC. | $54.87 | 2020 | |
| Harrow Eye, LLC | $47.86 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.61 | 2019-2021 | |
| Allergan, INC. | $37.06 | 2021 | |
| Astellas Pharma US INC | $28.70 | 2024 | Izervay |
| Tarsus Pharmaceuticals, INC. | $25.29 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $23.01 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.57 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $20.73 | 2024 | Tyrvaya |
| Amgen INC. | $19.86 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.